3-Piperidinamine, N,4-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (3R,4R)-

Product Name
3-Piperidinamine, N,4-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (3R,4R)-
CAS No.
2097982-05-1
Chemical Name
3-Piperidinamine, N,4-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (3R,4R)-
Synonyms
3-Piperidinamine, N,4-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (3R,4R)-
CBNumber
CB15909561
Molecular Formula
C13 H19 N5
Formula Weight
245.32
MOL File
2097982-05-1.mol
More
Less

Hazard and Precautionary Statements (GHS)

3-Piperidinamine, N,4-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (3R,4R)- Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

3-Piperidinamine, N,4-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (3R,4R)- Suppliers

China 7 India 1 Global 8
Pharmaffiliates Analytics and Synthetics P. Ltd
Tel
--
Fax
--
Email
mktg@pharmaffiliates.com
Country
India
ProdList
6739
Advantage
58
More
Less

View Lastest Price from 3-Piperidinamine, N,4-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (3R,4R)- manufacturers

ShenZhen H&D Pharmaceutical Technology Co., LTD
Product
Tofacitinib Impurity J 2097982-05-1
Price
US $0.00-0.00/mg
Min. Order
10mg
Purity
0.98
Supply Ability
10g
Release date
2024-05-20

2097982-05-1, 3-Piperidinamine, N,4-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (3R,4R)-Related Search:

3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI) (3R,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine 3-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyriMidin-4-yl)(Methyl)aMino)-4-Methylpiperidin-1-yl)-3-oxopropanenitrile 3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine (3S,4S)-1-Benzyl-N,4-dimethylpiperidin-3-amine 3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanoic acid Carbamic acid, [(3R,4R)-4-methyl-3-piperidinyl]-, 1,1-dimethylethyl ester (9CI) (3S,4S)-Tofacitinib 3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide 6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine N-methyl-N-((3S,4S)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine 3-((3R,4S)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile 3-Piperidinamine, 1-(2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-N,4-dimethyl-, (3R,4R)- N-((3S,4S)-1-benzyl-4-Methylpiperidin-3-yl)-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine (3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile 2,4-DICHLORO-7H-PYRROLO2,3-DPYRIMIDINE Tofacitinib Impurity 6

  • 3-Piperidinamine, N,4-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (3R,4R)-
  • 2097982-05-1